HUMA: Humacyte, Inc. Stock

by  •  • Comments Off on HUMA: Humacyte, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 764.52
Enterprise Value ($M) 649.02
Book Value ($M) 26.15
Book Value / Share 0.22
Price / Book 29.23
NCAV ($M) -17.39
NCAV / Share -0.15
Price / NCAV -43.97

Profitability (mra)
Return on Invested Capital (ROIC) -2.13
Return on Assets (ROA) -0.58
Return on Equity (ROE) -1.29

Liquidity (mrq)
Quick Ratio 8.37
Current Ratio 8.37

Balance Sheet (mrq) ($M)
Current Assets 117.93
Assets 161.47
Liabilities 135.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -100.05
Net Income -110.78

Cash Flow Statement (mra) ($M)
Cash From Operations -73.31
Cash from Investing -0.17
Cash from Financing 4.51

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-08 13D/A Niklason Laura E 8.40 1.02

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 231,700 3,500,163 6.62
2024-05-16 787,957 4,114,960 19.15
2024-05-15 1,098,393 4,278,803 25.67
2024-05-14 1,212,209 1,291,652 93.85
2024-05-13 498,709 3,869,380 12.89

(click for more detail)

Similar Companies
HALO – Halozyme Therapeutics, Inc. HLVX – HilleVax, Inc.
HOWL – Werewolf Therapeutics, Inc. IBRX – ImmunityBio, Inc.
IDXX – IDEXX Laboratories, Inc.


Financial data and stock pages provided by
Fintel.io